|
| 36747626 | Scientific civility and academic performance. | bioRxiv | 2024 |
| 37856427 | Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen. | ACS Infect Dis | 2024 |
| 38009954 | COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. | Microbiol Spectr | 2024 |
| 38095433 | Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". | mBio | 2024 |
| 37984358 | Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients. | Semin Thromb Hemost | 2024 |
| 38078750 | The American Academy of Microbiology discusses gain-of-function research of concern (GOFROC) and enhanced potential pandemic pathogens (ePPP). | mBio | 2024 |
| 37967364 | Late Administration and Corticosteroid Usage Explain Inefficacy in COVID-19 Convalescent Plasma Trial. | J Infect Dis | 2024 |
| 38055643 | Estimating the size of fields in biomedical sciences. | mSystems | 2024 |
| 36747626 | Scientific civility and academic performance. | bioRxiv | 2024 |
| 37967364 | Late Administration and Corticosteroid Usage Explain Inefficacy in COVID-19 Convalescent Plasma Trial. | J Infect Dis | 2024 |
| 38078750 | The American Academy of Microbiology discusses gain-of-function research of concern (GOFROC) and enhanced potential pandemic pathogens (ePPP). | mBio | 2024 |
| 37856427 | Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen. | ACS Infect Dis | 2024 |
| 38009954 | COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. | Microbiol Spectr | 2024 |
| 38055643 | Estimating the size of fields in biomedical sciences. | mSystems | 2024 |
| 37984358 | Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients. | Semin Thromb Hemost | 2024 |
| 38095433 | Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". | mBio | 2024 |
| 36345608 | Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV-2 in a US-like population. | Transfusion | 2023 |
| 35579509 | Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. | Clin Infect Dis | 2023 |
| 36345608 | Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV-2 in a US-like population. | Transfusion | 2023 |
| 36342497 | Lower anti-spike levels in B-cell-depleted patients after convalescent plasma transfusion suggest the need for repeated doses. | Br J Haematol | 2023 |
| 36001740 | Convalescent plasma in oncohematological patients. | Hematol Oncol | 2023 |
| 36074894 | Recent Hybrid Plasma Better Neutralizes Omicron Sublineages Than Old Hyperimmune Serum. | Clin Infect Dis | 2023 |
| 35941021 | Rethinking the role of COVID-19 convalescent plasma in the critically ill. | Transfus Apher Sci | 2023 |
| 36329567 | Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of Evusheld. | J Med Virol | 2023 |
| 36268708 | Absence of pathogenic viruses in COVID-19 convalescent plasma. | Transfusion | 2023 |
| 38030896 | Global warming could drive the emergence of new fungal pathogens. | Nat Microbiol | 2023 |
| 37937981 | The value of observational registry studies for the next infectious disease emergency. | mBio | 2023 |
| 38024560 | Top five unanswered questions in fungal cell surface research. | Cell Surf | 2023 |
| 38014111 | <i>Cryptococcus neoformans</i> rapidly invades the murine brain by sequential breaching of airway and endothelial tissues barriers, followed by engulfment by microglia. | bioRxiv | 2023 |
| 37659419 | Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. | Lancet Microbe | 2023 |
| 38010310 | Factors related to the severity of research misconduct administrative actions: An analysis of office of research integrity case summaries from 1993 to 2023. | Account Res | 2023 |
| 37732210 | The structure of a <i>C. neoformans</i> polysaccharide motif recognized by protective antibodies: A combined NMR and MD study. | bioRxiv | 2023 |
| 37724870 | Early antibody treatment, inflammation, and risk of post-COVID conditions. | mBio | 2023 |
| 37986923 | Thermal and pigment characterization of environmental fungi in the urban heat island of Baltimore City. | bioRxiv | 2023 |
| 37721902 | Disaster mycology | Biomedica | 2023 |
| 37572569 | Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment. | Drug Resist Updat | 2023 |
| 37884396 | Mechanisms of Alternaria pathogenesis in animals and plants. | FEMS Microbiol Rev | 2023 |
| 37882546 | An account of American Academy of Microbiology reforms and pandemic operations. | mBio | 2023 |
| 37790378 | Neutron Scattering Analysis of <i>Cryptococcus neoformans</i> Polysaccharide Reveals Solution Rigidity and Repeating Fractal-like Structural Patterns. | bioRxiv | 2023 |
| 37554952 | The emergency use authorization for COVID-19 convalescent plasma reduced mortality. | Health Sci Rep | 2023 |
| 37859995 | Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis. | Mayo Clin Proc Innov Qual Outcomes | 2023 |
| 36519923 | Virology in Peril and the Greater Risk To Science. | mSphere | 2023 |
| 36840577 | Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined. | mBio | 2023 |
| 36519890 | Virology in Peril and the Greater Risk To Science. | J Virol | 2023 |
| 36519848 | Virology in Peril and the Greater Risk To Science. | mBio | 2023 |
| 36897098 | A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses. | mBio | 2023 |
| 36897089 | A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses. | J Virol | 2023 |
| 36897078 | A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses. | mSphere | 2023 |
| 36712033 | Cuticular profiling of insecticide resistant <i>Aedes aegypti</i>. | bioRxiv | 2023 |
| 37399022 | Convalescent Plasma Versus Hyperimmune Immunoglobulins. | Clin Infect Dis | 2023 |